Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study

Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study

Detalles Bibliográficos
Autores principales:	Thomas Nyström, Irene Santos-Pardo, Fredric Hedberg, Johan Wardell, Nils Witt, Yang Cao, Leif Bojö, Bo Nilsson, Johan Jendle
Formato:	Artículo
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018-02-01
Colección:	Frontiers in Endocrinology
Materias:	longitudinal functional reserve index liraglutide subclinical heart failure tissue Doppler echocardiography type 2 diabetes
Acceso en línea:	http://journal.frontiersin.org/article/10.3389/fendo.2018.00050/full

Ejemplares similares

Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study
por: Thomas Nyström, et al.
Publicado: (2017-11-01)

Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride
por: J. Jendle, et al.
Publicado: (2021-12-01)

Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial
por: Nikolai N. Scherbak, et al.
Publicado: (2023-09-01)

Liraglutide overdose: A case report and an updated review
por: Sharafaldeen Bin Nafisah, et al.
Publicado: (2020-01-01)

Metformin exerts synergistic anti-proliferative effects with Liraglutide in human umbilical vein endothelial cells (HUVECs)
por: Amir Shadboorestan, et al.
Publicado: (2022-04-01)

Liraglutide Drug Loading with Double Layered Hydroxide- Synthesis and Characterization
por: Sevan Adeeb Doshan, et al.
Publicado: (2020-06-01)

Liraglutide and Exercise: A Possible Treatment for Obesity?
por: Ana Paula Azevêdo Macêdo, et al.
Publicado: (2022-08-01)

Effect of metformin versus metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome
por: Chuan Xing, et al.
Publicado: (2022-08-01)

Hippocampal Ganglioside Composition is Altered by Metformin and Liraglutide Treatment in A High-Fat High-Sugar Diet Rat Model
por: Marin Kuharić, et al.
Publicado: (2023-01-01)

Efficacy and safety of liraglutide in Indian adolescents with obesity
por: I. S. Kochar, et al.
Publicado: (2019-06-01)

Ejaculate quality indicators of men with asthenozoospermia and asthenoteratozoospermia by treatment of obesity with liraglutide
por: D. N. Bobkov, et al.
Publicado: (2021-10-01)

Therapeutic efficacy of liraglutide versus metformin in modulating the gut microbiota for treating type 2 diabetes mellitus complicated with nonalcoholic fatty liver disease
por: Xing Ying, et al.
Publicado: (2023-01-01)

Liraglutide abrogates nephrotoxic effects of chemotherapies
por: Cong Xu, et al.
Publicado: (2023-03-01)

Role of liraglutide in Alzheimer’s disease pathology
por: Maria Vargas-Soria, et al.
Publicado: (2021-06-01)

Long-term efficacy of liraglutide in Indian patients with Type 2 diabetes in a real-world setting
por: Parjeet Kaur, et al.
Publicado: (2016-01-01)

Comparison of Postprandial Insulin Levels in Withania Coagulans and Liraglutide Treated Diabetic Rats
por: Abdul Samad, Shazia Ali, Noman Sadiq
Publicado: (2018-12-01)

Comparison of the effects of liraglutide and sibutramine in obese patients
por: G. A. Matveev, et al.
Publicado: (2021-07-01)

Continuation of Liraglutide during Fasting is not Associated with Hypoglycaemia
por: Rosalie Koot, et al.
Publicado: (2017-10-01)

Clinical Impact of Liraglutide as a Treatment of Obesity
por: Alruwaili H, et al.
Publicado: (2021-03-01)

Effects of liraglutide and empagliflozin added to insulin therapy in patients with type 2 diabetes: A randomized controlled study
por: Hirotatsu Nakaguchi, et al.
Publicado: (2020-11-01)

Histopathological Study of Liraglutide on Renal Deterioration Progression Induced by Doxorubicin
por: Hayder Hussein Luaibi, et al.
Publicado: (2019-12-01)

The effects of liraglutide on the characteristics of blood parameters and testicular tissue induced diabetes and obesity in mice
por: Saied Mohammadzadeh, et al.
Publicado: (2024-08-01)

Low dose liraglutide in Indian patients with type 2 diabetes in the real world setting
por: Debmalya Sanyal, et al.
Publicado: (2013-01-01)

Obezitenin Medikal Tedavisinde Liraglutide Etkinliğinin Araştırılması
por: Murat Kose, et al.
Publicado: (2023-09-01)

The Discovery and Development of Liraglutide and Semaglutide
por: Lotte Bjerre Knudsen, et al.
Publicado: (2019-04-01)

First GLP-1 analog liraglutide: the result of clinical trails on efficacy
por: Alexander Sergeevich Ametov, et al.
Publicado: (2011-12-01)

Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetes
por: Damien Denimal, et al.
Publicado: (2023-05-01)

Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction
por: Qi Q, et al.
Publicado: (2017-07-01)

Comparative cardiovascular and renal outcomes of Liraglutide versus Dulaglutide in Asian type 2 diabetes patients
por: Jhih-Wei Dai, et al.
Publicado: (2024-11-01)

Liraglutide; A New Hope for Obese Diabetics
por: Ajeet Kumar, et al.
Publicado: (2020-12-01)

Complex vasoactivity of liraglutide. Contribution of three gasotransmitters
por: Eszter Sélley, et al.
Publicado: (2015-05-01)

Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial ( 2023;47:668-81)
por: Nikolai N. Scherbak, et al.
Publicado: (2023-11-01)

The Efficacy and Safety of Liraglutide 3.0 mg for Weight Management in Obese Non-Diabetic Saudi Outpatients
por: Albaker W, et al.
Publicado: (2021-11-01)

Liraglutide for Weight Management in the Real World: Significant Weight Loss Even if the Maximal Daily Dose Is Not Achieved
por: Liesbet Trenson, et al.
Publicado: (2021-11-01)

Combination therapies in the management of type 2 diabetes: the use of insulin degludec/liraglutide
por: Minze MG, et al.
Publicado: (2016-03-01)

Liraglutide in adolescents with simple obesity and gastrointestinal comorbidities: treatment experience
por: A. V. Vitebskaya, et al.
Publicado: (2023-07-01)

Molecular mechanisms of semaglutide and liraglutide as a therapeutic option for obesity
por: Rafael Tamayo-Trujillo, et al.
Publicado: (2024-04-01)

Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetes
por: Campbell RK, et al.
Publicado: (2010-07-01)

The Effects of Liraglutide on In Vitro Fertilization in Mice Following Experimental Diabetes
por: Rafieh Khalily, et al.
Publicado: (2020-03-01)

Low dose of liraglutide combined with metformin leads to a significant weight loss in Chinese Han women with polycystic ovary syndrome: a retrospective study
por: Xuefeng Long, et al.
Publicado: (2023-12-01)